相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Amino acid substitutions in core and NS5A regions of the HCV genome can predict virological decrease with pegylated interferon plus ribavirin therapy
Shosuke Kitamura et al.
ANTIVIRAL THERAPY (2010)
Modulation of metallothionein isoforms is associated with collagen deposition in proliferating keloid fibroblasts in vitro
Pearl P. -C. Toh et al.
EXPERIMENTAL DERMATOLOGY (2010)
Hepatic ISG Expression Is Associated With Genetic Variation in Interleukin 28B and the Outcome of IFN Therapy for Chronic Hepatitis C
Masao Honda et al.
GASTROENTEROLOGY (2010)
Novel Serum Markers of Fibrosis Progression for the Follow-Up of Hepatitis C Virus-infected Patients
Frederique Caillot et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Antifibrotic Effects of CXCL9 and Its Receptor CXCR3 in Livers of Mice and Humans
Hermann E. Wasmuth et al.
GASTROENTEROLOGY (2009)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Yasuhito Tanaka et al.
NATURE GENETICS (2009)
Transient and etiology-related transcription regulation in cirrhosis prior to hepatocellular carcinoma occurrence
Frederique Caillot et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
HCV Induces Oxidative and ER Stress, and Sensitizes Infected Cells to Apoptosis in SCID/Alb-uPA Mice
Michael A. Joyce et al.
PLOS PATHOGENS (2009)
Establishment of an infectious genotype 1b hepatitis C virus clone in human hepatocyte chimeric mice
Takashi Kimura et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Interferon signaling and treatment outcome in chronic hepatitis C
Magdalena Sarasin-Filipowicz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response
Jordan J. Feld et al.
HEPATOLOGY (2007)
Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines
Takayuki Abe et al.
JOURNAL OF VIROLOGY (2007)
Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis C virus and its susceptibility to interferon
Nobuhiko Hiraga et al.
FEBS LETTERS (2007)
Dual effect of APOBEC3G on Hepatitis B virus
Chiemi Noguchi et al.
JOURNAL OF GENERAL VIROLOGY (2007)
Critical role of PA28γ in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis
Kohji Moriishi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Prediction of response to pegylated interferon and ribavirin in hepatitis C by polymorphisms in the viral core protein and very early dynamics of viremia
Norio Akuta et al.
INTERVIROLOGY (2007)
High expression of APOBEC3G in patients infected with hepatitis C virus
Yoshihiro Komohara et al.
JOURNAL OF MOLECULAR HISTOLOGY (2006)
Different signaling pathways in the livers of patients with chronic hepatitis B or chronic hepatitis C
Masao Honda et al.
HEPATOLOGY (2006)
Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1
Hari S. Conjeevaram et al.
GASTROENTEROLOGY (2006)
Host-specific response to HCV infection in the chimeric SCID-beige/Alb- uPA mouse model: Role of the innate antiviral immune response
Kathie-Anne Walters et al.
PLOS PATHOGENS (2006)
Genomic response to interferon-α in chimpanzees:: Implications of rapid downregulation for hepatitis C kinetics
RE Lanford et al.
HEPATOLOGY (2006)
Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication
Marianne Bonvin et al.
HEPATOLOGY (2006)
E2 of hepatitis C virus inhibits apoptosis
SH Lee et al.
JOURNAL OF IMMUNOLOGY (2005)
Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity
XD Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Liver gene expression signature of mild fibrosis in patients with chronic hepatitis C
T Asselah et al.
GASTROENTEROLOGY (2005)
Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus
M Tsuge et al.
HEPATOLOGY (2005)
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction
T Kawai et al.
NATURE IMMUNOLOGY (2005)
VISA is an adapter protein required for virus-triggered IFN-β signaling
LG Xu et al.
MOLECULAR CELL (2005)
Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF3
RB Seth et al.
CELL (2005)
APOBEC-mediated interference with hepadnavirus production
C Rösler et al.
HEPATOLOGY (2005)
G to A hypermutation of hepatitis B virus
C Noguchi et al.
HEPATOLOGY (2005)
Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy
N Akuta et al.
INTERVIROLOGY (2005)
HVR-1 quasispecies modifications occur early and are correlated to initial but not sustained response in HCV-infected patients treated with pegylated- or standard-interferon and ribavirin
I Abbate et al.
JOURNAL OF HEPATOLOGY (2004)
APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase
R Suspène et al.
NUCLEIC ACIDS RESEARCH (2004)
Near completely humanized liver in mice shows human-type metabolic responses to drugs
C Tateno et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
APOBEC-mediated editing of viral RNA
KN Bishop et al.
SCIENCE (2004)
Proteasome activator PA28γ-dependent nuclear retention and degradation of hepatitis C virus core protein
K Moriishi et al.
JOURNAL OF VIROLOGY (2003)
Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif
R Mariani et al.
CELL (2003)
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
B Mangeat et al.
NATURE (2003)
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA
H Zhang et al.
NATURE (2003)
Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin
JH Hoofnagle et al.
HEPATOLOGY (2003)
Hypermutation of HIV-1 DNA in the absence of the Vif protein
D Lecossier et al.
SCIENCE (2003)
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
RA Irizarry et al.
BIOSTATISTICS (2003)
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias
BM Bolstad et al.
BIOINFORMATICS (2003)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns et al.
LANCET (2001)
Hepatitis C virus replication in mice with chimeric human livers
DF Mercer et al.
NATURE MEDICINE (2001)
分享论文
